Canaccord Genuity raises Enovix stock price target to $22 on AI-1 platform

Canaccord Genuity raised its price target for Enovix (ENVX) to $22 from $20, maintaining a Buy rating, after the company reported stronger-than-expected Q2 2025 results with revenue and EPS beating estimates. The upgrade reflects optimism for Enovix's new AI-1 battery platform, touted for its high energy density and fast-charging capabilities, though Canaccord acknowledges the need for official OEM orders and manufacturing scale. Despite recent stock volatility, analysts largely maintain a "Strong Buy" consensus, with InvestingPro suggesting the stock is undervalued.

Analysis

Canaccord Genuity has raised its price target for Enovix Corporation (ENVX) to $22.00 from $20.00, reaffirming a Buy rating, a move prompted by the company's strong second-quarter 2025 financial results and optimism surrounding its new technology. Enovix significantly surpassed analyst expectations, reporting revenue of $7.5 million against a projected $5.57 million and a smaller-than-anticipated loss per share of -$0.13 versus an expected -$0.19. The upgrade is fundamentally driven by the potential of Enovix's new AI-1 battery platform, which is positioned as the first smartphone battery to achieve an energy density of 900 Wh/L+ with a 1,000-cycle life. Despite this technological promise and a healthy balance sheet characterized by more cash than debt and a current ratio of 4.37x, significant execution risks remain. Canaccord's analysis acknowledges that Enovix must still secure an official order from a leading smartphone OEM and prove its manufacturing process can scale effectively. This dichotomy is reflected in the stock's recent performance, where it has fallen nearly 29% in the past week, contrasting sharply with the strong buy consensus and a projected 49% revenue growth for the current year.

Key Decisions for Investors

• Given the disconnect between the stock's recent 29% drop and the positive analyst action, investors could consider the volatility a potential entry point, but should closely watch for the announcement of a definitive purchase order from a major OEM as the next critical catalyst.
• The wide range of analyst price targets ($10 to $100) underscores the high-risk, high-reward nature of this pre-commercialization technology company; therefore, risk management and appropriate position sizing are crucial.
• Investors should scrutinize upcoming quarterly reports for concrete evidence of manufacturing scalability and progress on customer adoption, as these are the key hurdles that must be overcome to justify Canaccord's discounted cash flow-based valuation and the broader bullish thesis.